Recently, Duan et al. reported the biological roles of circMYLK/miR-195/cyclin D1 axis in the development and progression of laryngeal squamous cell carcinoma, providing a novel therapeutic target for these patients [17]. Here, CCND1 is linked to laryngeal squamous cell carcinoma.